CRISPR/Cas-based technologies have revolutionized genetic approaches to addressing a wide range of neurobiological questions. The ability of CRISPR/Cas to introduce mutations into target genes allows us to perform in vivo loss-of-function experiments without generating genetically engineered mice. However, the lack of a reliable method to determine genotypes of individual CRISPR/Cas-transfected cells has made it impossible to unambiguously identify the genetic cause of their phenotypes in vivo. Here, we report a strategy for single-cell genotyping in CRISPR/Cas-transfected neurons that were phenotypically characterized in vivo. We show that re-sectioning of cortical slices and subsequent laser microdissection allow us to isolate individual CRISPR/Cas-transfected neurons. Sequencing of PCR products containing a CRISPR/Cas-targeted genomic region in single reference neurons provided genotypes that completely correspond with those deduced from their target protein expression and phenotypes. Thus, our study establishes a powerful strategy to determine the causality between genotypes and phenotypes in CRISPR/Cas-transfected neurons.
You may also like
Visible calcium concentrations
October 11, 2023Max Planck Institute for Biological Intelligence
Distributed workload in the fly brain
October 9, 2023Max Planck Institute for Biological Intelligence
Insulin-like hormones critical for brain plasticity
August 7, 2023Max Planck Florida Institute for Neuroscience
A Butterfly Effect
July 27, 2023Max Planck Florida Institute for Neuroscience
Deep learning models to study sentence comprehension...
June 28, 2023Max Planck Institute for Psycholinguistics
How the brain slows down when we focus our gaze
June 28, 2023Max Planck Institute for Biological Cybernetics